OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Estimated Population Health Benefits of Intensive Systolic Blood Pressure Treatment Among SPRINT-Eligible US Adults
Catherine G. Derington, Adam P. Bress, Ransmond O. Berchie, et al.
American Journal of Hypertension (2023) Vol. 36, Iss. 9, pp. 498-508
Closed Access | Times Cited: 7
Catherine G. Derington, Adam P. Bress, Ransmond O. Berchie, et al.
American Journal of Hypertension (2023) Vol. 36, Iss. 9, pp. 498-508
Closed Access | Times Cited: 7
Showing 7 citing articles:
Diagnosis and management of resistant hypertension
Ernesto L. Schiffrin, Naomi D.L. Fisher
BMJ (2024), pp. e079108-e079108
Open Access | Times Cited: 12
Ernesto L. Schiffrin, Naomi D.L. Fisher
BMJ (2024), pp. e079108-e079108
Open Access | Times Cited: 12
Effectiveness of Hypertension Management Strategies in SPRINT‐Eligible US Adults: A Simulation Study
Fengdi Zhang, Kelsey B. Bryant, Andrew E. Moran, et al.
Journal of the American Heart Association (2024) Vol. 13, Iss. 2
Open Access | Times Cited: 4
Fengdi Zhang, Kelsey B. Bryant, Andrew E. Moran, et al.
Journal of the American Heart Association (2024) Vol. 13, Iss. 2
Open Access | Times Cited: 4
RNA Injection Every 6 Months to Improve Adherence and Lower Blood Pressure in Patients With Hypertension
Ernesto L. Schiffrin
JAMA (2024) Vol. 331, Iss. 9, pp. 733-733
Closed Access | Times Cited: 4
Ernesto L. Schiffrin
JAMA (2024) Vol. 331, Iss. 9, pp. 733-733
Closed Access | Times Cited: 4
Approach to Resistant Hypertension: A Review of Recent Pharmacological Advances
Lorenzo Arvanitis, Christian Mewaldt, Anna K. Krawisz, et al.
Current Treatment Options in Cardiovascular Medicine (2024) Vol. 27, Iss. 1
Closed Access | Times Cited: 1
Lorenzo Arvanitis, Christian Mewaldt, Anna K. Krawisz, et al.
Current Treatment Options in Cardiovascular Medicine (2024) Vol. 27, Iss. 1
Closed Access | Times Cited: 1
Intensive Systolic Blood Pressure Lowering Strategy in Adults With Hypertension: Is Lower Still Better?
M. Yousufuddin, Ebrahim Barkoudah, Rehan Qayyum
American Journal of Hypertension (2023) Vol. 36, Iss. 9, pp. 481-484
Closed Access | Times Cited: 1
M. Yousufuddin, Ebrahim Barkoudah, Rehan Qayyum
American Journal of Hypertension (2023) Vol. 36, Iss. 9, pp. 481-484
Closed Access | Times Cited: 1
What Constitutes Adequate Control of High Blood Pressure? Current Considerations
Donald E. Casey, Alexander Blood, Stephen D. Persell, et al.
Mayo Clinic Proceedings Innovations Quality & Outcomes (2024) Vol. 8, Iss. 4, pp. 384-395
Open Access
Donald E. Casey, Alexander Blood, Stephen D. Persell, et al.
Mayo Clinic Proceedings Innovations Quality & Outcomes (2024) Vol. 8, Iss. 4, pp. 384-395
Open Access
Annual Cost of Implementing Intensive Systolic Blood Pressure Goals in the United States
Jordan B. King, Swati Sakhuja, Catherine G. Derington, et al.
Journal of the American Heart Association (2024) Vol. 13, Iss. 18
Open Access
Jordan B. King, Swati Sakhuja, Catherine G. Derington, et al.
Journal of the American Heart Association (2024) Vol. 13, Iss. 18
Open Access
